Companies

Johnson & Johnson to stop selling baby powder in US, Canada

Prashasti Awasthi Mumbai | Updated on May 21, 2020 Published on May 20, 2020

Healthcare giant Johnson & Johnson is going to stop selling all its talc-based Johnson's Baby Powder in the United States and Canada, as per a BBC report.

This came after the company was mounted with charges relating to the production of substandard  talc based baby powder.

“This discontinuation is only effective in North America and was made due to dwindling consumer demand for the product, due in part to ongoing misleading litigation advertising. In other regions around the world, including India, where there is significantly higher demand for the product, talc-based Johnson’s Baby Powder continues to be available,” said a company spokesperson.

Johnson & Johnson informed that it would stop the sales of the product, which makes up about 0.5 per cent of its US consumer health business, in the coming months. However, retail shops across the US can continue selling the product to exhaust the existing inventory.

The move comes after years of litigation where Johnson & Johnson has been ordered to pay out billions of dollars in compensation. However, the company has defended the quality of its products. 

The firm faces more than 16,000 consumer lawsuits alleging that the company's talc products were contaminated with asbestos, a known carcinogen.

The firm mentioned that due to the overwhelming number of lawsuits, the demand for talc-based products has fallen significantly in North America. Johnson & Johnson said, "due in large part to changes in consumer habits and fuelled by misinformation around the safety of the product".

It said it had faced "a constant barrage" of lawyers advertising for clients to sue the firm.

"We remain steadfastly confident in the safety of talc-based Johnson's Baby Powder. Decades of independent scientific studies by medical experts around the world support the safety of our product," it said.

Johnson and Johnson noted that the move has been taken as a part to reassess its business strategy prompted by the global pandemic.

It said in October that its testing had found no asbestos in its Baby Powder after tests conducted by the US Food and Drug Administration discovered trace amounts.

The firm is appealing against a 2018 order to pay $4.7bn (£3.6bn) in damages to 22 women who alleged that its talc products caused them to develop ovarian cancer, BBC report added.

Published on May 20, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.